| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/05/2009 | WO2009132928A2 Molecular markers for cancer prognosis |
| 11/05/2009 | WO2009132909A1 A method for predicting a clinical response of a patient suffering from or at risk of developing cancer towards a given mode of treatment |
| 11/05/2009 | WO2009132860A1 Substances and methods for a dna based profiling assay |
| 11/05/2009 | WO2009132820A1 Suspension arrays for species-species interaction studies |
| 11/05/2009 | WO2009132423A1 Acetaminophen assay |
| 11/05/2009 | WO2009132397A1 Methods and agents for modulating the level and/or activity of hif-2 alpha protein |
| 11/05/2009 | WO2009109809A3 Atomic force microscope as an analyzing tool for biochip |
| 11/05/2009 | WO2009103018A3 Methods and kits for extraction of dna |
| 11/05/2009 | WO2009103010A3 Alpha-synuclein kinase |
| 11/05/2009 | WO2009102747A8 Alternatively transcribed genes associated with memory consolidation |
| 11/05/2009 | WO2009100262A3 Oral care methods and systems |
| 11/05/2009 | WO2009100243A3 Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients |
| 11/05/2009 | WO2009100215A3 Detection of clostridium difficile |
| 11/05/2009 | WO2009095786A3 Methods and kits for the rapid determination of patients at high risk of death during septic shock |
| 11/05/2009 | WO2009095567A3 Method for studying v(d)j combinatory diversity |
| 11/05/2009 | WO2009095000A3 Method for sequencing an rna molecule by means of mass spectrometry |
| 11/05/2009 | WO2009092982A3 Method for detecting and/or identifying clostridium difficile |
| 11/05/2009 | WO2009092112A3 Selective photostimulation to induce cell proliferation |
| 11/05/2009 | WO2009091375A3 Rapid detection of volatile organic compounds for identification of mycobacterium tuberculosis in a sample |
| 11/05/2009 | WO2009091187A3 Bio-disc |
| 11/05/2009 | WO2009088837A3 Methods and products to target, capture and characterize stem cells |
| 11/05/2009 | WO2009087689A4 Novel primers for identification of astrocytoma, it's grades and glioblastoma prognosis |
| 11/05/2009 | WO2009085704A9 Compositions and methods to detect candida albicans nucleic acid |
| 11/05/2009 | WO2009079232A9 Method and apparatus for micro-organism capture |
| 11/05/2009 | WO2009076229A3 Methods to determine if a subject will respond to a bcr-abl inhibitor |
| 11/05/2009 | WO2009054996A8 Systems and methods for viral therapy |
| 11/05/2009 | WO2009049223A3 Methods and compositions for the site-selective incorporation of fluorinated amino acids into polypeptides |
| 11/05/2009 | WO2008115415A8 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 11/05/2009 | WO2008097773A8 Methods and devices for diagnosis of appendicitis |
| 11/05/2009 | WO2008067195A8 Genemap of the human genes associated with crohn's disease |
| 11/05/2009 | WO2008054598A8 Panel of biomarkers for prediction of fti efficacy |
| 11/05/2009 | WO2008034896A8 Identification and quantification of a plurality of biological (micro)organisms or their components |
| 11/05/2009 | WO2008030845A8 Methods of predicting distant metastasis of lymph node-negative primary breast cancer using biological pathway gene expression analysis |
| 11/05/2009 | WO2007147168A8 Attenuation of hyperoxia-induced cell death with mitochondrial aldehyde dehydrogenase |
| 11/05/2009 | WO2007098671A8 A method for preparing the primers for in vitro identifying mutations within larged vestibular aqueduct syndromic hearing loss pds gene and the use thereof |
| 11/05/2009 | WO2007097574A8 Molecular marker associated with tmv resistance and use thereof |
| 11/05/2009 | WO2007084855A8 Genetic markers for boar taint |
| 11/05/2009 | WO2005064009A9 Classification of cancer |
| 11/05/2009 | WO2004063710A9 Mark-pap system (method, kit, solution & accessories) processes for producing and using the same |
| 11/05/2009 | US20090275738 Use of A33 antigens and jam-it |
| 11/05/2009 | US20090275735 Monoclonal antibodies to human ctla-8 (il-17a) |
| 11/05/2009 | US20090275649 Compositions And Methods For Identifying Modulars Of TRPV2 |
| 11/05/2009 | US20090275639 Usp47 inhibtors and methods to induce apoptosis |
| 11/05/2009 | US20090275636 Picornavirus and uses thereof |
| 11/05/2009 | US20090275635 Screening method |
| 11/05/2009 | US20090275633 Novel Tumour Suppressor |
| 11/05/2009 | US20090275632 Methods of diagnosis and treatment |
| 11/05/2009 | US20090275608 Methods of diagnosing and treating parp-mediated diseases |
| 11/05/2009 | US20090275572 Fab i inhibitors |
| 11/05/2009 | US20090275510 Compositions and Methods for Inducing or Inhibiting Activities of Selected Human Cells |
| 11/05/2009 | US20090275498 Novel peptides |
| 11/05/2009 | US20090275497 Method for identifying modulators of the activity of ion-channels receptors |
| 11/05/2009 | US20090275480 Universal readout for target identification using biological microarrays |
| 11/05/2009 | US20090275125 Human T1R2 Taste Receptor Nucleic Acids and Cells Containing These Nucleic Acids |
| 11/05/2009 | US20090275118 Bacteria Detecting Instrument, Bacteria Detecting Method, and Bacteria Detecting Kit |
| 11/05/2009 | US20090275104 Genetically engineered glucanase for use in detergent industry, textiles and preparation of peptide antibiotics |
| 11/05/2009 | US20090275100 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 11/05/2009 | US20090275079 Novel genes encoding novel proteolytic enzymes |
| 11/05/2009 | US20090275075 Methods and systems for ensuring the security of food commodities |
| 11/05/2009 | US20090275074 System and Method for Performing G Protein Coupled Receptor (GPCR) Cell Assays Using Waveguide-Grating Sensors |
| 11/05/2009 | US20090275073 Diagnosis device and diagnosis method |
| 11/05/2009 | US20090275072 In Vitro bio-reactor circuit |
| 11/05/2009 | US20090275071 Diagnostic composition and article for monitoring intravaginal infections |
| 11/05/2009 | US20090275070 Compounds and Methods of Identifying, Synthesizing, Optimizing and Profiling Protein Modulators |
| 11/05/2009 | US20090275069 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells |
| 11/05/2009 | US20090275068 Method of determining chymase activity with secretory leukocyte protease inhibitor |
| 11/05/2009 | US20090275067 Method of acquiring hepatic oval cells |
| 11/05/2009 | US20090275066 Immobilization of membrane porteins onto supports via an amphiphile |
| 11/05/2009 | US20090275065 Methods and compounds for detecting beta-lactamase activity |
| 11/05/2009 | US20090275064 Methods to identify therapeutic agents |
| 11/05/2009 | US20090275063 Distinguishing cells in a sample by inactivating extracellular enzyme before releasing intracellular enzyme |
| 11/05/2009 | US20090275052 analysis apparatus copmrising a rotary motor, an optical energy conversion device, a signal molecular output device, a power resource system, a protective layer, a supporting material and a bilayer lipid membrane, used for detecting biological macromolecules and viruses |
| 11/05/2009 | US20090275050 14273 receptor, a novel G-protein coupled receptor |
| 11/05/2009 | US20090275045 Method for detecting mammary cancer cells |
| 11/05/2009 | US20090275044 Using E6 viral transcript expression as diagnostic indicator in detection and classification of cervical cancers |
| 11/05/2009 | US20090275043 Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus |
| 11/05/2009 | US20090275042 Method of Detecting and/or Quantifying Expression of a Target Protein Candidate in a Cell, and a Method of Identifying a Target Protein of a Small Molecule Modulator |
| 11/05/2009 | US20090275041 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 11/05/2009 | US20090275040 Detecting bcl-b expression in cancer and uses thereof |
| 11/05/2009 | US20090275039 Methods for detection and quantification of small rna |
| 11/05/2009 | US20090275038 Method and apparatus for forensic screening |
| 11/05/2009 | US20090275037 Fluorescent double stranded dna binding dyes |
| 11/05/2009 | US20090275036 Systems and methods for real time single molecule sequence determination |
| 11/05/2009 | US20090275035 Primers for human mitochondrial hypervariable region and method for detecting human dna by using the primers |
| 11/05/2009 | US20090275034 Temperature control system |
| 11/05/2009 | US20090275033 Uses of BNIPXL-Beta in premature canities |
| 11/05/2009 | US20090275032 Reprogramming a cell by inducing a pluripotent gene through use of an HDAC modulator |
| 11/05/2009 | US20090275031 Biomolecular nano device |
| 11/05/2009 | US20090275030 Cell calcification suppressing proteins, and genes of the proteins |
| 11/05/2009 | US20090275029 Systems and Methods to Quantify and Amplify Both Signaling and Probes for CDNA Chips and Gene Expression Microarrays |
| 11/05/2009 | US20090275028 Method of detecting target nucleic acid |
| 11/05/2009 | US20090275027 Medium scale intergration of molecular logic gates in an automaton |
| 11/05/2009 | US20090275026 Primer and Probe for Detection of Mycobacterium Intracellulare, and Method for Detection of Mycobacterium Intracellulare by Using the Primer and Probe |
| 11/05/2009 | US20090275025 HPV Detection and Quantification by Real-Time Multiplex Application |
| 11/05/2009 | US20090275024 Novel centrerosome-associated protein and applications thereof |
| 11/05/2009 | US20090275023 Compositions and methods for detecting borrelia afzelii |
| 11/05/2009 | US20090275022 Stat6 effects on livestock animal growth |
| 11/05/2009 | US20090275021 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 11/05/2009 | US20090275020 Traceability of Cellular Cycle Anomalies Targeting Oncology and Neurodegeneration |
| 11/05/2009 | US20090275019 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells |